How a formula is built

Seventy-One Per Cent Of One Capsule: How This Joint Panel Spends Its Budget

Five hundred of this capsule's 699 mg of declared actives are one ingredient. Seven others share the remaining 199 mg and four of them weigh 8 mg each. Read the panel as a budget rather than as an ingredient list and the formula becomes legible in about thirty seconds.

By FlexGuard Team · Last updated October 29, 2026 · 8 min read · How a formula is built · Reviewed by Dr. Edgar Martorell, MD

A panel as a budget, not a list

A two-piece hard capsule comes in standard sizes, and the one used for most supplements holds somewhere around half a gram of powder. The exact fill weight depends on how dense the material is, how well it flows and how hard it is tamped, but the order of magnitude does not move: a capsule is a few hundred milligrams of space.

Part of that space is not available. A filler is usually needed so a small quantity of active powder fills the shell evenly, which is what the rice flour on this label is doing, and a flow agent is often needed so the machine can run at all.

So a joint panel is a budget of roughly half a gram, allocated across however many names the front of the bottle is going to carry. On this bottle 699 mg of declared actives went across eight rows, and the interesting question is not how many capsules a day it asks for but where those milligrams went.

One thing this article is deliberately not about: how often a dose is taken. Frequency is a separate question from allocation, and it does not change the arithmetic below.

Why 1,500 mg is the number that breaks everything

The trouble starts with the best-studied ingredient in the category.

The NIH-funded GAIT trial randomised 1,583 people to glucosamine at 1,500 mg a day, chondroitin at 1,200 mg, both, an anti-inflammatory or placebo. The Cochrane review pooled twenty studies and drew on the same daily figure. Whatever you think the literature shows, it is a literature about 1,500 mg a day.

Fifteen hundred milligrams is three capsules of nothing else. Add chondroitin at the 800 to 1,200 mg its own pooled trials used and you are at five or six capsules a day for two ingredients.

That is the fork in the road, and it arrives before any decision about which botanicals are fashionable or what the front label should say.

A common size 0 capsule holds roughly half a gram of powder, and the fill weight varies with how dense the material is. The right-hand column is an order of magnitude rather than a specification.

The two answers, and what each one costs

A formulator has exactly two ways out of that, and both are in every pharmacy in the country.

Depth: fewer rows, at the amounts the research used

Two ingredients, three or four capsules a day, and a panel that matches the literature row for row. The cost is the regimen: four capsules a day for two months is something a meaningful number of people will not complete, and a product nobody finishes produces no answer at all.

Breadth: more rows, at a fraction of the amounts

Eight ingredients, one capsule a day, and a panel where one row is in the neighbourhood of its research and the rest are below it. The cost is the amounts, and it is visible on the panel to anybody who knows what the trials used.

Neither column is the right answer in general. Which one is right depends entirely on whether you want one thing done at the studied amount or several things attempted.

What this panel spent its budget on

The arithmetic is short, because the label does it for you.

• Glucosamine sulfate, 500 mg. That is 500 of the capsule's 699 mg, or seventy-one per cent of the entire budget on one row.
• Boswellia serrata, 67 mg. Nearly ten per cent, and the only row in the same order of magnitude as the extract its own trials used.
• Chondroitin sulfate and turmeric root, 50 mg each. Seven per cent apiece.
• Quercetin, methionine, MSM and bromelain, 8 mg each. Thirty-two milligrams between them, under five per cent of the capsule for four of the eight names.

Read that list as a budget rather than as an ingredient list and the formula becomes legible. Seventy-one per cent went on the ingredient with the most research, ten per cent went on the botanical with the most direct joint evidence, and the remaining fifth was spread across six names, four of which are there in name.

Whether that is a good allocation is a judgement. What is not a judgement is that the allocation is printed, and that the ingredients page sets every row against the amount its own research used.

The argument for one a day, made honestly

There is a real case for breadth and it is not about marketing. It is about whether anybody actually takes the product.

Adherence is the quiet problem in this whole category. A joint supplement needs eight to twelve weeks before anybody could form a view, because that is the span the trials used, and a four-capsule regimen across that period is a great deal of remembering.

One capsule beside a kettle, taken at the same moment every morning, is a habit. Four capsules taken with meals is a routine, and routines are the things that lapse in the second week of a busy month.

So a defensible version of this formula's case runs: a smaller amount somebody actually takes for sixty days beats a larger amount they abandon on day nineteen. That argument is honest as far as it goes. What it cannot do is turn an untested amount into a tested one.

Why breadth also sells better, which is not nothing

It would be naive to pretend the choice is made on pharmacology alone.

A front label listing eight ingredients reads as more generous than one listing two, and most buyers count names rather than milligrams. A product carrying MSM appears in searches for MSM whatever the amount, and MSM's own literature runs in grams a day, so the name is doing search work that the 8 mg could not do on its own.

None of that makes a breadth formula dishonest. It makes the panel the only place the question can be settled, which is why a label that prints eight numbers is worth more than a label that prints eight names.

The version of this you cannot check

There is a third option and it is the one to avoid.

A proprietary blend prints several ingredient names and one combined total. The formulator still faced the same capsule-volume problem and still made the same allocation; the buyer simply cannot see what it was.

Everything in this article becomes impossible in front of a blend. You cannot tell whether seventy per cent went on one row or whether eleven ingredients each got a twentieth of the total. The arithmetic is not merely hard, it is unavailable.

That is the strongest single thing on this bottle, and it is worth stating in an article that spends most of its length on the amounts: FlexGuard prints all eight numbers. The criticism on this website is possible because the label made it possible.

Five questions for the next bottle you pick up

1. How many capsules a day? Multiply the panel by that number before comparing anything to anything.
2. Add the actives up. A few hundred milligrams is a breadth formula; a couple of grams across several capsules is a depth one.
3. Find the largest row and its share. If one row is most of the capsule, that is the product, and the rest is company.
4. Ask whether the largest row reaches its own trial amount. For glucosamine the number to hold it against is 1,500 mg a day.
5. Check for a blend. If the panel gives one total for several names, none of the first four questions can be answered and that is the answer.

Those five take under a minute and they work on any bottle in this category, including this one. Running them on this panel produces a fair description in one sentence: a glucosamine capsule at a third of the trial amount, with one plant row in the right neighbourhood and six smaller companions, taken once a day.

References